The economic burden of pneumonia in children under five in Uganda

Elizabeth Ekirapa-Kiracho1, Gatien De Broucker2, Anthony Ssebagereka1

  • 1Makerere University School of Public Health, Uganda.

Vaccine: X
|May 26, 2021
PubMed

Insights

Pneumonia treatment incurs significant household costs in Uganda, with nearly 40% of families facing catastrophic expenditures. Understanding these economic impacts is crucial for public health interventions.

Area of Science:

  • Public Health
  • Health Economics
  • Epidemiology

Background:

  • Pneumonia causes millions of deaths globally and is a leading cause of child mortality in Uganda.
  • The economic burden of pneumonia on households and caregivers is not well-documented.

Purpose of the Study:

  • To estimate the economic costs of a pneumonia episode from household, government, and societal perspectives in Uganda.

Main Methods:

  • A cost-of-illness study was conducted using an ingredient-based approach.
  • Data were collected from 48 healthcare facilities across public and private sectors.
  • Household costs included direct (medical, non-medical) and indirect (human capital approach) costs.

Main Results:

  • The average societal cost per pneumonia episode was $42, with hospitalized cases costing $62 and ambulatory cases $16.
  • Public healthcare facilities incurred lower costs ($12 hospitalized, $7 ambulatory) compared to private facilities.
  • Approximately 39% of households experienced catastrophic health expenditures due to pneumonia treatment costs.

Conclusions:

  • Pneumonia treatment imposes a substantial economic burden on households in Uganda.
  • Caregiver out-of-pocket payments vary significantly across public and private healthcare sectors.
  • Findings highlight the need for financial protection strategies to mitigate the economic impact of pneumonia.
Abstract

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.8K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
455
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
549
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
446
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
287
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
784